Coronary interventions in octogenarians - Contra;... imot: Koronare intervensjoner etter 80-årsalderen

Tidsskrift for den Norske Laegeforening

Volumn 123, Issue 12, 2003, Pages 1735-1736

  Kristiansen, Ivar Sønbø ^a  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOCARDIOGRAPHY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY SURGERY; COST EFFECTIVENESS ANALYSIS; GERIATRIC DISORDER; GERIATRIC SURGERY; HEALTH CARE COST; HUMAN; SHORT SURVEY; TRANSLUMINAL CORONARY ANGIOPLASTY; AGED; ARTICLE; COST BENEFIT ANALYSIS; ECONOMICS; ETHICS; HEART SURGERY; QUALITY OF LIFE;

AGED; AGED, 80 AND OVER; CARDIAC SURGICAL PROCEDURES; COST-BENEFIT ANALYSIS; HUMANS; QUALITY OF LIFE;

EID: 0142058084     PISSN: 00292001     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (9)

1. Weinstein MC, Stason WB. Cost-effectiveness of interventions to prevent or treat coronary heart disease. Annu Rev Public Health 1985; 6: 41-63.
2. Hovland A, Jønland K, Wiseth R. Koronar angiografi hos pasienter over 80 år. Tidsskr Nor Lægeforen 2003; 123: 1668-70.
3. Dahl PE, Andreassen L. Hjertekirurgi hos pasienter over 80 år. Tidsskr Nor Lægeforen 2003; 123: 1671-3.
4. Trial of invasive versus medical therapy in elderly patients with chronic symptomatic coronary-artery disease (TIME): a randomised trial. Lancet 2001; 358: 951-7.
5. Minai K, Horie H, Takahashi M, Nozawa M, Kinoshita M. Long-term outcome of primary percutaneous transluminal coronary angioplasty for low-risk acute myocardial infarction in patients older than 80 years: a single-center, open, randomized trial. Am Heart J 2002; 143: 497-505.
6. Johannesson M, Jonsson B, Kjekshus J, Olsson AG, Pedersen TR, Wedel H. Cost effectiveness of simvastatin treatment to lower cholesterol levels in patients with coronary heart disease. Scandinavian Simvastatin Survival Study Group. N Engl J Med 1997; 336: 332-6.
7. Kristiansen IS, Gyrd-Hansen D, Nexoe J, Nielsen JB. Number needed to treat: easily understood and intuitively meaningful? Theoretical considerations and a randomized trial. J Clin Epidemiol 2002; 55: 888-92.
8. Kristiansen IS. Hvor mye bør samfunnet være villig til å betale for helseforbedringer? I: Bringedal B, Iversen T, Kristiansen IS. Verdien av liv og helse. HERO Skriftserie 2003: 6. Oslo: Universitetet i Oslo, 2003.
9. Williams A. Intergenerational equity: an exploration of the «fair innings» argument. Health Econ 1997; 6: 117-32.